314 related articles for article (PubMed ID: 12143246)
1. Genetic analysis of xanthogranulomatous cholecystitis: precancerous lesion of gallbladder cancer?
Takada M; Horita Y; Okuda S; Okumoto S; Samizo M; Wada T; Kuroda Y; Maeda S
Hepatogastroenterology; 2002; 49(46):935-7. PubMed ID: 12143246
[TBL] [Abstract][Full Text] [Related]
2. Xanthogranulomatous cholecystitis: a clinicopathological study of its association with gallbladder carcinoma.
Zhuang PY; Zhu MJ; Wang JD; Zhou XP; Quan ZW; Shen J
J Dig Dis; 2013 Jan; 14(1):45-50. PubMed ID: 23134201
[TBL] [Abstract][Full Text] [Related]
3. The value of p53 protein expression in gallbladder carcinoma: analysis of 60 cases.
da Rocha AO; Coutinho LM; Scholl JG; Leboutte LD
Hepatogastroenterology; 2004; 51(59):1310-4. PubMed ID: 15362740
[TBL] [Abstract][Full Text] [Related]
4. Xanthogranulomatous cholecystitis: a chronic inflammatory pseudotumor of the gallbladder.
Howard TJ; Bennion RS; Thompson JE
Am Surg; 1991 Dec; 57(12):821-4. PubMed ID: 1746802
[TBL] [Abstract][Full Text] [Related]
5. Microsatellite instability in preneoplastic and neoplastic lesions of the gallbladder.
Roa JC; Roa I; Correa P; Vo Q; Araya JC; Villaseca M; Guzmán P; Schneider BG
J Gastroenterol; 2005 Jan; 40(1):79-86. PubMed ID: 15692793
[TBL] [Abstract][Full Text] [Related]
6. Sporadic TP53 transition mutations in chronic cholecystitis are possibly linked to gallbladder carcinogenesis.
Yanagisawa N; Yamashita K; Kuba T; Okayasu I
Anticancer Res; 2010 Nov; 30(11):4443-9. PubMed ID: 21115891
[TBL] [Abstract][Full Text] [Related]
7. Fragile histidine triad (FHIT) gene and its association with p53 protein expression in the progression of gall bladder cancer.
Priya TP; Kapoor VK; Krishnani N; Agrawal V; Agarwal S
Cancer Invest; 2009 Aug; 27(7):764-73. PubMed ID: 19452299
[TBL] [Abstract][Full Text] [Related]
8. Promoter methylation profile in preneoplastic and neoplastic gallbladder lesions.
García P; Manterola C; Araya JC; Villaseca M; Guzmán P; Sanhueza A; Thomas M; Alvarez H; Roa JC
Mol Carcinog; 2009 Jan; 48(1):79-89. PubMed ID: 18543280
[TBL] [Abstract][Full Text] [Related]
9. TP53 abnormalities are frequent and early events in the sequential pathogenesis of gallbladder carcinoma.
Moreno M; Pimentel F; Gazdar AF; Wistuba II; Miquel JF
Ann Hepatol; 2005; 4(3):192-9. PubMed ID: 16177659
[TBL] [Abstract][Full Text] [Related]
10. Genetic alterations involved in the development of gallbladder carcinomas from Greek patients.
Saetta A; Lazaris AC; Michalopoulos NV; Davaris PS
Hepatogastroenterology; 2001; 48(41):1284-8. PubMed ID: 11677947
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous presence of xanthogranulomatous cholecystitis and gallbladder cancer.
Kwon AH; Sakaida N
J Gastroenterol; 2007 Aug; 42(8):703-4. PubMed ID: 17701136
[No Abstract] [Full Text] [Related]
12. High frequency of p53 gene mutation in adenocarcinomas of the gallbladder.
Fujii K; Yokozaki H; Yasui W; Kuniyasu H; Hirata M; Kajiyama G; Tahara E
Cancer Epidemiol Biomarkers Prev; 1996 Jun; 5(6):461-6. PubMed ID: 8781743
[TBL] [Abstract][Full Text] [Related]
13. Xanthogranulomatous cholecystitis: a premalignant condition?
Ghosh M; Sakhuja P; Agarwal AK
Hepatobiliary Pancreat Dis Int; 2011 Apr; 10(2):179-84. PubMed ID: 21459725
[TBL] [Abstract][Full Text] [Related]
14. Differentiating xanthogranulomatous cholecystitis from wall-thickening type of gallbladder cancer: added value of diffusion-weighted MRI.
Kang TW; Kim SH; Park HJ; Lim S; Jang KM; Choi D; Lee SJ
Clin Radiol; 2013 Oct; 68(10):992-1001. PubMed ID: 23622795
[TBL] [Abstract][Full Text] [Related]
15. Xanthogranulomatous cholecystitis mimicking stage IV gallbladder cancer.
Enomoto T; Todoroki T; Koike N; Kawamoto T; Matsumoto H
Hepatogastroenterology; 2003; 50(53):1255-8. PubMed ID: 14571712
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor single-nucleotide polymorphism in gallbladder cancer.
Mishra K; Behari A; Kapoor VK; Khan MS; Prakash S; Agrawal S
J Gastroenterol Hepatol; 2013 Oct; 28(10):1678-85. PubMed ID: 23962084
[TBL] [Abstract][Full Text] [Related]
17. Coexistence of xanthogranulomatous cholecystitis and gallbladder adenocarcinoma: a fortuitous association?
Limaiem F; Chelly B; Hassan F; Haddad I; Ben Slama S; Lahmar A; Bouraoui S; Mzabi-Regaya S
Pathologica; 2013 Aug; 105(4):137-9. PubMed ID: 24471194
[TBL] [Abstract][Full Text] [Related]
18. p53, carcinoembryonic antigen and carbohydrate antigen 19.9 expression in gall bladder cancer, precursor epithelial lesions and xanthogranulomatous cholecystitis.
Agrawal V; Goel A; Krishnani N; Pandey R; Agrawal S; Kapoor VK
J Postgrad Med; 2010; 56(4):262-6. PubMed ID: 20935395
[TBL] [Abstract][Full Text] [Related]
19. Xanthogranulomatous cholecystitis.
Moldavsky M; Hadary A; Turani H
Acta Cytol; 1998; 42(4):1050-1. PubMed ID: 9684605
[No Abstract] [Full Text] [Related]
20. A case of simultaneous xanthogranulomatous cholecystitis and carcinoma of the gallbladder.
Lee HS; Joo KR; Kim DH; Park NH; Jeong YK; Suh JH; Nam CW
Korean J Intern Med; 2003 Mar; 18(1):53-6. PubMed ID: 12760270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
